Results
610
Large Cap Companies that analysts expect to have high earnings, revenue or cash flow growth in the next 3 years.
610 companies
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
---|---|---|---|---|---|---|---|---|---|---|---|
ONON | US$57.88 | 5.2% | 89.4% | US$18.3b | US$60.34 | PE131.5x | E29.4% | n/a | Consumer Durables | ||
ALNY | US$243.99 | -4.7% | 31.0% | US$31.7b | US$299.11 | PS15x | E70.3% | n/a | Pharmaceuticals & Biotech | ||
ARES | US$183.70 | 4.8% | 56.4% | US$57.1b | US$181.00 | PE85.8x | E38.5% | 2.0% | Diversified Financials | ||
CRDO | US$77.25 | 15.2% | 300.7% | US$12.7b | US$73.00 | PS52.6x | E65.9% | n/a | Semiconductors | ||
600760 | CN¥49.35 | 2.5% | 21.2% | CN¥136.0b | CN¥53.90 | PE55.3x | E29.3% | 0.8% | Capital Goods | ||
NVDA | US$132.00 | -4.9% | 163.6% | US$3.3t | US$172.38 | PE51.3x | E25.1% | 0.03% | Semiconductors | ||
SRPT | US$126.79 | -1.7% | 35.0% | US$11.8b | US$183.60 | PE99.4x | E42.5% | n/a | Pharmaceuticals & Biotech | ||
9992 | HK$94.20 | 1.5% | 371.5% | HK$124.9b | HK$90.26 | PE76.7x | E35.9% | 0.3% | Retail | ||
RHM | €612.80 | 1.2% | 115.0% | €27.1b | €721.93 | PE38.8x | E29.9% | 0.9% | Capital Goods | ||
NU | US$11.74 | -1.6% | 40.9% | US$57.4b | US$15.64 | PB7.4x | E28.7% | n/a | Banks | ||
MRVL | US$124.78 | 16.6% | 108.9% | US$104.5b | US$118.06 | PS20.1x | E69.5% | 0.2% | Semiconductors | ||
511243 | ₹1,246.10 | -6.8% | -0.3% | ₹1.0t | ₹1,518.12 | PE27.2x | E21.9% | 0.2% | Diversified Financials | ||
CGPOWER | ₹770.80 | -3.3% | 69.1% | ₹1.2t | ₹767.40 | PE132.1x | E23.4% | 0.2% | Capital Goods | ||
SUZLON | ₹69.56 | 4.5% | 85.5% | ₹949.3b | ₹74.83 | PE98.9x | E39.4% | n/a | Capital Goods | ||
300308 | CN¥125.99 | 2.3% | 55.8% | CN¥139.2b | CN¥191.56 | PE30.1x | E32.6% | 0.3% | Tech | ||
SGEN | US$228.74 | 4.5% | 76.5% | US$43.2b | US$228.91 | PS18.8x | E71.8% | n/a | Pharmaceuticals & Biotech | ||
FM | CA$18.60 | -9.2% | 79.2% | CA$16.1b | CA$21.94 | PS2.3x | E72.9% | n/a | Materials | ||
A196170 | ₩301,500.00 | -5.2% | 317.0% | ₩16.1t | ₩565,000.00 | PS216x | E140.6% | n/a | Pharmaceuticals & Biotech | ||
300502 | CN¥133.70 | 14.4% | 157.7% | CN¥94.8b | CN¥151.97 | PE49.8x | E36.7% | 0.1% | Tech | ||
BESI | €128.50 | 2.6% | -6.7% | €10.1b | €135.99 | PE57.7x | E30.2% | 1.7% | Semiconductors | ||
KSPI | US$103.22 | -6.5% | 9.8% | US$20.1b | US$133.84 | PE10.6x | E23.7% | 6.3% | Diversified Financials | ||
BAM | CA$83.67 | 2.8% | 62.6% | CA$34.4b | CA$74.64 | PE54.9x | E88.3% | 2.6% | Diversified Financials | ||
SMCI | US$33.44 | -24.3% | 3.8% | US$21.3b | US$40.32 | PE16.2x | E24.3% | n/a | Tech | ||
600989 | CN¥15.66 | -5.1% | 9.4% | CN¥114.8b | CN¥21.74 | PE18.2x | E38.5% | 1.8% | Materials |